Revance Therapeutics logo
Revance Therapeutics RVNC
$ 3.09 0.49%

Quarterly report 2024-Q3
added 11-07-2024

report update icon

Revance Therapeutics P/E Ratio 2011-2024 | RVNC

Annual P/E Ratio Revance Therapeutics

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
-1.48 -7.07 -3.2 -5.23 -6.09 -4.48 -8.51 -6.05 -6.87 -4.96 - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
-1.48 -8.51 -5.39